TrialClinical and translational science2026

A Multipart Phase 1 Study to Assess Safety and Pharmacokinetics of Ibuzatrelvir in Healthy Participants and Dose Selection for a Dose-Ranging Study.

Ravi Shankar P Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.